Higher risk of liver cancer seen in women with intrahepatic cholestasis of pregnancy

the ONA take:

Researchers at the Sahlgrenska Academy found that women with intrahepatic cholestasis of pregnancy (ICP) are at increased risk of hepatobiliary cancer and immune-mediated and cardiovascular diseases later in life.

Using the Swedish Medical Birth Register and the Swedish Patient Register, the investigators identified 11,388 women with ICP and 113,893 women without ICP who gave birth between 1973 and 2009.

Study findings showed risk for cancer in the biliary tree and risk for liver cancer were 2.5 times higher and 3.5 times higher, respectively, compared with matched controls. In addition, patients with ICP were found to be at higher risk for thyroid disease, diabetes, psoriasis, and Crohn’s disease. Women with both ICP and preeclampsia during pregnancy had a slightly higher risk for cardiovascular disease.

The investigators recommend follow-up of serum liver tests 6 to 12 weeks after delivery for all women with ICP, and further evaluation by a hepatologist if serum liver tests results are elevated.

Psychosocial challenges of pregnancy-associated breast cancer (PABC)
Women with intrahepatic cholestasis of pregnancy (ICP) are at increased risk of hepatobiliary cancer.
In a new study of more than 125,000 pregnant women in Sweden, researchers at the Sahlgrenska Academy found that the risk of hepatobiliary cancer and immune-mediated and cardiovascular diseases later in life is higher in women with intrahepatic cholestasis of pregnancy (ICP) than in women without this condition.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs